1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. C4 THERAPEUTICS INC
C4 Therapeutics Inc
XNAS: CCCC
4.15 0.23 (5.87%)
3.4M
XNAS Volume

XNAS 18 Jun, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for C4 Therapeutics Inc is on 24 Jun 2026 for the purpose of C4 Therapeutics Inc Annual General Meeting for 2026 See details

C4 Therapeutics Inc - CCCC - stock price prediction, stock price target, analyst ratings from 7 analysts

C4 Therapeutics Inc has a share price target of US$ 13, revenue growth forecast of -47.3%, and profit growth estimate of -13.5% for FY26, based on top 7 analyst calls.